Summary
Written by ThreatClusterfrom victim profile, leak postThe group claims they stole 187.88 GB of data from Hangzhou Qihan Biotech Co., Ltd., with the leak currently listed in countdown for publication. Victim profile on the leak page lists domain www.qihanbio.com, sector biotechnology, and country China. The group describes Qihan Biotech as Hangzhou-based, specializing in gene editing and cell/organ therapies, developing immune-privileged cells and xenogeneic organs to treat cancer and organ failure, with a stated aim to make these therapies accessible worldwide.
Describes what the group claims on its leak site. A listing is not confirmation that a breach occurred.
What was taken
Qihan Biotech is a Hangzhou‑based biotech company specializing in gene editing and cell/organ therapies. It develops immune‑privileged cells and xenogeneic organs to treat cancer and organ failure. The company aims to make these therapies accessible worldwide.
Also stated on the leak page
Fields this group publishes that do not map to a standard column. Labels are the site's own.
- CUSTODY & ESCROW
- All target disclosures and research materials are held under sealed cryptographic escrow until verified publication. Unreleased materials remain inaccessible to third parties.
- EDGE RUNTIME & LOGGING
- This public node operates on an ephemeral memory model with zero persistent logging. No user sessions, identity keys, or raw archive databases are retained on edge routing layers.
Leak-site images (1)
Images from the victim's leak listing. Thumbnails scraped from the onion page are blurred by default — click a thumbnail to view.